Amgen (AMGN) Revenue (2009 - 2025)

Amgen's Revenue history runs 17 years deep, the most recent figure standing at $36.8 billion for FY2025.

• In Q1 2026, Revenue rose 5.76% year-over-year to $8.6 billion; the TTM figure through Mar 2026 stood at $37.2 billion (up 9.07% YoY), while the FY2025 annual figure was $36.8 billion, up 9.95% from the prior year.
• Revenue was $36.8 billion for FY2025 at Amgen, up from $33.4 billion in the prior year.
• In the past five years, Revenue ranged from a high of $36.8 billion in FY2025 to a low of $26.0 billion in FY2021.
• Historically, Revenue has averaged $30.1 billion across 5 years, with a median of $28.2 billion in 2023.
• The sharpest annual moves came in 2022 and 2024: Revenue advanced 1.32% in 2022, then grew 18.57% in 2024.
• A 5-year view of Revenue shows it stood at $26.0 billion in 2021, then advanced by 1.32% to $26.3 billion in 2022, then grew by 7.09% to $28.2 billion in 2023, then advanced by 18.57% to $33.4 billion in 2024, then climbed by 9.95% to $36.8 billion in 2025.
• The last three Revenue figures came in at $36.8 billion (FY2025), $33.4 billion (FY2024), and $28.2 billion (FY2023), per Business Quant data.